Wall St hit by capital tax increase report; dollar ticks up



* Oil ticks up with eyes on virus, Libya

* Dollar index posting strongest gain this month (Updates prices, changes comment, dateline; previous LONDON)

By Rodrigo Campos

NEW YORK, April 22 (Reuters) - Global stocks fell on Thursday weighed by Wall Street after a report that the Biden administration will propose a sharp increase to capital gains tax, while the dollar index gained as the euro and pound gave back some of the month's gains.

Oil prices were little changed as concerns over Libyan output offset worries that rising coronavirus cases in India and Japan would cause energy demand to decline.

On Wall Street, indexes turned lower after a Bloomberg report that the Biden administration would propose to lift the capitals gains tax to near 40% for wealthy individuals, nearly double the current rate.

"If they’re going to tax people more and their net is going to fall, the value of that instrument is lower. Incentives matter," said Kim Forrest, chief investment officer at Bokeh Capital Partners in Pittsburgh.

"A lot of money that's in the market at this point is non taxable, and I don't think people do that calculation. Whenever they see news (like this), they just sell, they want to take the gains this year."

The Dow Jones Industrial Average .DJI fell 394.34 points, or 1.16%, to 33,742.97, the S&P 500 .SPX lost 44.88 points, or 1.08%, to 4,128.54 and the Nasdaq Composite .IXIC dropped 153.66 points, or 1.1%, to 13,796.56. MSCI's gauge of stocks across the globe .MIWD00000PUS shed 0.35% and the pan-European STOXX 600 index .STOXX rose 0.68%. Emerging market stocks .MSCIEF rose 0.28%.

MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS closed 0.28% higher, while Japan's Topix .TOPX rose 1.82%.

Treasury yields fell alongside stocks on the capital gains tax issue.

Benchmark 10-year notes US10YT=RR last rose 3/32 in price to yield 1.5539%, from 1.564% late on Wednesday, remaining in a tight range so far this week.

Oil prices were in and out of positive territory as traders weighed lower output in Libya with concern over demand from India, the third-largest global consumer.

"The market realized that a global comeback in oil demand cannot come without a comeback of the world’s largest economies," said Bjornar Tonhaugen, head of oil markets at Rystad Energy, noting "India is diving deeper and deeper into a major crisis with infections setting new records every day."

U.S. crude CLc1 rose 0.02% to $61.36 per barrel and Brent LCOc1 was at $65.30, down 0.03% on the day.

In currency markets, the dollar =USD rose as the pound gave back some of its recent sharp gains while the euro was weighed by an ECB statement that was hopeful on the economic recovery but lacking in details about the stimulus removal.

U.S. Federal Reserve and Bank of Japan meetings follow next week.

The dollar index =USD rose 0.247%, with the euro EUR= down 0.22% to $1.2006.

The Japanese yen strengthened 0.02% versus the greenback at 108.05 per dollar, while Sterling GBP= was last trading at $1.3833, down 0.69% on the day.

The Russian ruble rose against the dollar after Moscow signaled an end to military drills near the Ukraine border, easing some of the geopolitical risk premium.

The ruble strengthened 1.77% versus the greenback at 75.57 per dollar.

Turkish markets suffered under the weight of expectations that U.S. President Joe Biden will formally recognize the massacre of Armenians by the Ottoman Empire during World War One as an act of genocide.

The lira lost 1.64% versus the U.S. dollar at 8.31.

Spot gold XAU= dropped 0.7% to $1,781.86 an ounce. Silver XAG= fell 1.83% to $26.09.



Global assets Link
Global currencies vs. dollar Link
Emerging markets Link
MSCI All Country Wolrd Index Market Cap Link



Additional reporting by Simon Jessop in London, Ross Kerber in
Boston, Lucia Mutikani in Washington, and David Henry and Scott
DiSavino in New York; Editing by Nick Zieminski



Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.